adj ep estim line consensu dialysi
busi deliv solid quarter off-set line item notabl kidney
revenu better estim driven better expect price
treatment growth bode well compani commerci price outlook
addit reiter dialysi oper incom guidanc
contempl account headwind assum intern
busi break even sometim late overal quarter solid
signal commerci price pressur normal see littl threat new
regul third parti premium support adjust ebitda ep
estim reflect move dmg discontinu oper updat tax rate
outlook roll estim unchang po base
ebitda estim estim multipl reflect dmg sale
reiter buy rate improv commerci outlook upsid dmg
sale remain top hc facil pick
dmg sale track still expect close
seek regulatori approv sale davita medic group dmg
continu target close result move dmg discontinu
oper dialysi guidanc effect becom enterpris guidanc
quarter focu dmg sale capit deploy first walk
base case assumpt capit deploy provid scenario
analysi potenti upsid estim driven higher percentag
proce spent share repurchas meanwhil although left open
possibl spend money outsid dialysi indic move
would limit final review lt outlook dva core dialysi busi
dmg sale allow focu core busi overal estim
addit share repo beyond model could add ep could
repurchas stock next year
net dbt
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
davita inc lead dialysi provid
unit state compani oper
outpati clinic us serv
patient also oper countri
outsid us
commerci mix price stabil bode
well particularli given conserv
initi guidanc addit continu view
sale davita medic group dmg
posit use proce share
repurchas debt repay invest
health care servic outsid dialysi
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu dmg sale capit deploy first walk
base case assumpt capit deploy provid
scenario analysi potenti upsid estim driven higher percentag
proce spent share repurchas meanwhil although left open
possibl spend money outsid dialysi indic move
would limit final review lt outlook dva core dialysi busi
dmg sale allow focu core busi overal estim
addit share repo beyond model could add ep could
repurchas stock next year
dmg sale use proce
dmg sale nice accret use proce addit share
repurchas debt repay invest health care servic outsid
dialysi compani emphas intent pay debt also note
expect spend signific portion proce share repurchas
current assum increment share repurchas dmg sale
proce addit assum goe debt repay bring
dva gross leverag goe balanc sheet avail make
limit invest health care servic note repo combin
modest repo compani free cash-flow assum model mean
forecast repurchas stock next two year
tabl potenti use proce dmg sale current assumpt
proce dmg sale
invest health care servic
addit share repo beyond model could add ep
although assum achiev gross leverag leverag
target net leverag basi impli compani anoth billion
cash avail share repo would still abl oper within target rang
show potenti impact lever net leverag
net leverag note compani essenti back assert would
like move leverag repo increment accret model
like somewher note increment repo would push total
repo dva stock next two year
tabl potenti impact share repo differ leverag assumpt
focu core dialysi busi
dmg perform disappoint distract sale allow
focu core kidney busi show potenti lt outlook
expect organ volum growth averag line dva long-term target
non-acquir treatment growth ss volum growth view
sustain diabet obes hypertens lead caus kidney failur
grow percentag popul period see moder
volum broadli across health care stabil dialysi stand well
meanwhil deal add anoth volum lead total volum growth
rang
rate growth appear achiev medicar commerci price
stabil lead total revenu growth addit integr care
repres growth opportun long term
expect oper incom growth slightli revenu growth labor
cost pressur build could tailwind expect break-even
sometim
meanwhil expect net incom growth focus de-lever
share repurchas drive ep growth rang
els could invest
indic look invest area within health care servic
expect go health insur drug devic hospit
busi compani expect multi-billion dollar deal expand
servic offer howev compani see valu build capabl
help compani drive meaning growth long term
gener given dva difficulti dmg continu loss
intern busi believ market would gener prefer
compani spend vast major capit repo nevertheless
focus deal encourag compani comment
focus busi leverag core compet invest
would limit
quarter remain bullish commerci mix price appear
stabil bode well particularli given conserv initi guidanc
meanwhil view sale davita medic group dmg posit
use proce share repo debt repay invest overal quarter
solid see upsid estim capit deploy reiter buy
rate strong commerci outlook upsid dmg sale remain
po base ebitda estim high end
stand-alon histor rang ebitda commerci outlook
stabil dmg sale allow focu core dialysi busi
upsid risk po commerci mix better expect
reimburs better expect make chang third
downsid risk po commerci price pressur could continu
potenti commerci mix pressur manag care vast major dialysi
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
